Metaraminol tartrate - CAS 33402-03-8
Catalog number: 33402-03-8
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C9H13NO2.C4H6O6
Molecular Weight:
317.29
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Metaraminol is a stereoisomer of meta-hydroxynorephedrine, acts as An adrenergic agonist that increases both systolic and diastolic blood pressure.
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥95.0%
Appearance:
White powder
Synonyms:
3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol;2,3-dihydroxybutanedioic acid
Solubility:
10 mM in H2O
Storage:
Store at R. T.
MSDS:
Inquire
Application:
Used in the prevention and treatment of hypotension, particularly as a complication of anesthesia
Quality Standard:
Enterprise Standard/USP
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
357.9ºC at 760 mmHg
Melting Point:
175-177°C
InChIKey:
VENXSELNXQXCNT-YDYUUSCQSA-N
InChI:
InChI=1S/C9H13NO2.C4H6O6/c1-6(10)9(12)7-3-2-4-8(11)5-7;5-1(3(7)8)2(6)4(9)10/h2-6,9,11-12H,10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t6-,9-;/m0./s1
Canonical SMILES:
CC(C(C1=CC(=CC=C1)O)O)N.C(C(C(=O)O)O)(C(=O)O)O
Current Developer:
Merck
1.High-throughput screening of FDA-approved drugs using oxygen biosensor plates reveals secondary mitofunctional effects.
Sahdeo S1, Tomilov A1, Komachi K2, Iwahashi C3, Datta S1, Hughes O2, Hagerman P3, Cortopassi G1. Mitochondrion. 2014 Jul;17:116-25. doi: 10.1016/j.mito.2014.07.002. Epub 2014 Jul 14.
Repurposing of FDA-approved drugs with effects on mitochondrial function might shorten the critical path to mitochondrial disease drug development. We improved a biosensor-based assay of mitochondrial O2 consumption, and identified mitofunctional defects in cell models of LHON and FXTAS. Using this platform, we screened a 1600-compound library of clinically used drugs. The assay identified drugs known to affect mitochondrial function, such as metformin and decoquinate. We also identified several drugs not previously known to affect mitochondrial respiration including acarbose, metaraminol, gallamine triethiodide, and acamprosate. These previously unknown 'mitoactives' represent novel links to targets for mitochondrial regulation and potentially therapy, for mitochondrial disease.
2.A comparison of three vasopressors for tight control of maternal blood pressure during cesarean section under spinal anesthesia: Effect on maternal and fetal outcome.
Bhardwaj N1, Jain K, Arora S, Bharti N. J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):26-31. doi: 10.4103/0970-9185.105789.
PURPOSE: Maintaining systolic blood pressure (SBP) at 100% of baseline is best for fetal and maternal outcome. We hypothesized that irrespective of the vasopressor used, maintaining SBP at 100% of baseline with phenylephrine (P), metaraminol (M), or ephedrine (E) will produce the best fetal pH after cesarean section (LSCS) under subarachnoid block (SAB).
3.Propofol for adult procedural sedation in a UK emergency department: safety profile in 1008 cases.
Newstead B1, Bradburn S, Appelboam A, Reuben A, Harris A, Hudson A, Jones L, McLauchlan C, Riou P, Jadav M, Lloyd G. Br J Anaesth. 2013 Oct;111(4):651-5. doi: 10.1093/bja/aet168. Epub 2013 May 9.
BACKGROUND: Concerns exist regarding the safe use of propofol by Emergency Physicians for procedural sedation. The World SIVA International Sedation Task Force has recently created an adverse event tool, in an effort to standardize reporting. We present a safety analysis of our use of propofol using this tool.
4.Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study.
Currigan DA1, Hughes RJ, Wright CE, Angus JA, Soeding PF. Anesthesiology. 2014 Nov;121(5):930-6. doi: 10.1097/ALN.0000000000000430.
BACKGROUND: Vasopressor drugs, commonly used to treat systemic hypotension and maintain organ perfusion, may also induce regional vasoconstriction in specialized vascular beds such as the lung. An increase in pulmonary vascular tone may adversely affect patients with pulmonary hypertension or right heart failure. While sympathomimetics constrict pulmonary vessels, and vasopressin does not, a direct comparison between these drugs has not been made. This study investigated the effects of clinically used vasopressor agents on human isolated pulmonary and radial arteries.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 19216-56-9 Prazosin

Prazosin
(CAS: 19216-56-9)

Prazosin, a selective and orally active antagonist of adrenergic alpha-1, is a synthetic piperazine derivative to treat high blood pressure and anxiety, PTSD, a...

CAS 23239-51-2 Ritodrine Hydrochloride

Ritodrine Hydrochloride
(CAS: 23239-51-2)

Ritodrine HCl is a hydrochloride salt of ritodrine which is a β-2 adrenergic receptor agonist.Ritodrine (discontinued preparation: Yutopar) is a tocolytic drug,...

CAS 57149-07-2 Naftopidil

Naftopidil
(CAS: 57149-07-2)

Naftopidil is a selective α1-adrenergic receptor antagonist or alpha blocker with a Ki of 58.3 nM.

MK-761
(CAS: 65321-41-7)

MK-761 has beta adrenoceptor antagonist and vasodilating properties in a single molecule. It has beta adrenoceptor blocking activity in the isolated cat heart p...

CAS 119942-70-0 MK-912 hydrochloride

MK-912 hydrochloride
(CAS: 119942-70-0)

MK-912 is a potent new selective alpha 2-adrenergic receptor antagonist that is originated by Merck & Co for the treatment of Major depressive disorder. In Dec ...

CAS 30578-37-1 Amezinium methylsulfate

Amezinium methylsulfate
(CAS: 30578-37-1)

Amezinium methylsulfate, a sympathomimetic drug used for the treatment of low blood pressure, increases the arterial blood pressure and heart rate of anaestheti...

Nifenalol HCl

The hydrochloride of Nifenalol. Nifenalol is a beta-adrenoceptor antagonist used for the treatment of cardiovascular and cerebrovascular diseases such as hypert...

CAS 106401-52-9 Falintolol, (Z)-

Falintolol, (Z)-
(CAS: 106401-52-9)

Falintolol, (Z)- is a novel β-adrenergic antagonist.

CAS 51781-21-6 Carteolol Hydrochloride

Carteolol Hydrochloride
(CAS: 51781-21-6)

Carteolol HCl is a β-adrenoceptor antagonist, used for the treatment of glaucoma.

CHIR 2279
(CAS: 158198-45-9)

CHIR 2279, an isoquinolin derivative, was once studied against hypertension as an α1 adrenergic receptor antagonist.

CAS 498-45-3 Scopine

Scopine
(CAS: 498-45-3)

Scopine is the metabolite of anisodine, which is a α1-adrenergic receptor agonist and used in the treatment of acute circulatory shock.

CAS 161905-64-2 α1 adrenoceptor-MO-1

α1 adrenoceptor-MO-1
(CAS: 161905-64-2)

An S enantiomer which has affinity at alpha 1 adrenergic receptor

CAS 13392-18-2 Fenoterol

Fenoterol
(CAS: 13392-18-2)

Fenoterol, a phenol derivative, is a β2-adrenoceptor agonist and could be used as a bronchodilator and an antiasthmatic.

CAS 19237-84-4 Prazosin Hydrochloride

Prazosin Hydrochloride
(CAS: 19237-84-4)

Prazosin HCl, a quinazoline derivative, is the first of a new chemical class of antihypertensives.

CAS 3811-25-4 Clorprenaline

Clorprenaline
(CAS: 3811-25-4)

Clorprenaline is a beta-adrenergic receptor agonist.

CAS 13523-86-9 Pindolol

Pindolol
(CAS: 13523-86-9)

Pindolol, an Indole derivative, could be used in the treatment of hypertension and arrhythmia for acting as a 5-HT1A/1B receptor antagonist. IC50: 33nM(Ki).

ABT-866
(CAS: 258526-74-8)

ABT-866 is a novel alpha-adrenoceptor agent that demonstrates intrinsic activity at the α1A-adrenoceptor subtype present in the rabbit urethra (pD2=6.22, with 8...

CAS 57470-78-7 Celiprolol hydrochloride

Celiprolol hydrochloride
(CAS: 57470-78-7)

Celiprolol hydrochloride is a cardioselective β1-adrenergic blocker with potential antianginal and antihypertensive properties.

CAS 34391-04-3 Levalbuterol

Levalbuterol
(CAS: 34391-04-3)

Levalbuterol is a short-acting beta 2 adrenergic agonist. Levalbuterol binds to beta 2 adrenergic receptors and activates intracellular adenyl cyclase to promot...

CAS 72956-09-3 Carvedilol

Carvedilol
(CAS: 72956-09-3)

Carvedilol is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation.

Chemical Structure

CAS 33402-03-8 Metaraminol tartrate

Quick Inquiry

Verification code

Featured Items